ES545935A0 - Procedimiento para preparar nuevos derivados de dihidropiri-dina y sus sales y esteres - Google Patents

Procedimiento para preparar nuevos derivados de dihidropiri-dina y sus sales y esteres

Info

Publication number
ES545935A0
ES545935A0 ES545935A ES545935A ES545935A0 ES 545935 A0 ES545935 A0 ES 545935A0 ES 545935 A ES545935 A ES 545935A ES 545935 A ES545935 A ES 545935A ES 545935 A0 ES545935 A0 ES 545935A0
Authority
ES
Spain
Prior art keywords
dihidropiri
dina
esters
salts
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545935A
Other languages
English (en)
Other versions
ES8607932A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8607932A1 publication Critical patent/ES8607932A1/es
Publication of ES545935A0 publication Critical patent/ES545935A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES545935A 1984-08-07 1985-08-06 Procedimiento para preparar nuevos derivados de dihidropiri-dina y sus sales y esteres Expired ES8607932A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59165797A JPS6143165A (ja) 1984-08-07 1984-08-07 ジヒドロピリジン誘導体の製造法

Publications (2)

Publication Number Publication Date
ES8607932A1 ES8607932A1 (es) 1986-06-01
ES545935A0 true ES545935A0 (es) 1986-06-01

Family

ID=15819171

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545935A Expired ES8607932A1 (es) 1984-08-07 1985-08-06 Procedimiento para preparar nuevos derivados de dihidropiri-dina y sus sales y esteres

Country Status (7)

Country Link
US (1) US4795814A (es)
EP (1) EP0173126B1 (es)
JP (1) JPS6143165A (es)
KR (1) KR930009452B1 (es)
DE (1) DE3575295D1 (es)
DK (1) DK173807B1 (es)
ES (1) ES8607932A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
IT1275939B1 (it) 1995-03-20 1997-10-24 Lusochimica Spa Procedimento per la preparazione di 4 (nitrofenil) diidropiridine
CA2425561C (en) * 2003-04-14 2007-09-18 Brantford Chemicals Inc. Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof
CN105384682B (zh) * 2015-12-21 2018-04-20 芮城县虹桥药用中间体有限公司 一种西尼地平的制备方法
CN111072552B (zh) * 2019-12-11 2021-06-04 湖南九典制药股份有限公司 西尼地平的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
JPH0153873B2 (es) 1989-11-15
DK357385A (da) 1986-03-11
KR860001789A (ko) 1986-03-22
EP0173126B1 (en) 1990-01-10
JPS6143165A (ja) 1986-03-01
DK357385D0 (da) 1985-08-06
ES8607932A1 (es) 1986-06-01
US4795814A (en) 1989-01-03
KR930009452B1 (ko) 1993-10-04
DK173807B1 (da) 2001-11-12
DE3575295D1 (en) 1990-02-15
EP0173126A1 (en) 1986-03-05

Similar Documents

Publication Publication Date Title
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR227731A1 (es) Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales
ES543686A0 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
ES530269A0 (es) Derivados de indano y sus sales
ES541799A0 (es) Procedimiento de preparar derivados penam y sus sales
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
ES545935A0 (es) Procedimiento para preparar nuevos derivados de dihidropiri-dina y sus sales y esteres
AR240815A1 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
AR231543A1 (es) Procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilio y sus sales farmaceuticamente aceptables
ES552513A0 (es) Procedimiento para la preparacion de acidos 4-(isoxazolil)-tiazol-2-oxamicos y sus derivados
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
ES540778A0 (es) Procedimiento para preparar sales de derivados de oxazafos- forina
ES555708A0 (es) Procedimiento para preparar nuevos derivados de la quinoleina y sus sales complementarias acidas
ES540777A0 (es) Procedimiento para preparar sales de derivados de oxazafos- forina
ES544619A0 (es) Procedimiento para preparar acidos monoperoxidicarboxilicos y sus sales de metales alcalinos o alcalinoterreos
AR228437A1 (es) Procedimiento para preparar compuestos de 6-fenil-2-oxo-nicotinoilamoxicilina y sus sales
AR231538A1 (es) Un procedimiento para obtener derivados de 2-guanidintiazol y sus sales
MX163040B (es) Procedimiento para preparar acidos aciloxibencenosulfonicos y sus sales
ES553632A0 (es) Procedimiento para preparar esteres de acidos 6-bromopiridin-2-il-fosforicos
AR228852A1 (es) Procedimiento para preparar derivados de 1,1'bifenil-2-il-alquilamina y sus sales

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051114